News | April 23, 2026
India’s nutraceutical market sees entry of quantum-enhanced curcumin formulation
New formulation by Greenspace Herbs to target improved efficacy and lower dosage in curcumin supplements
New formulation by Greenspace Herbs to target improved efficacy and lower dosage in curcumin supplements
Approval for Albuterol Sulfate inhalation aerosol enables Cipla Limited to enter the $1.5 billion U.S. albuterol market
Neuland Laboratories reported an uptick in peptide-related engagements from Japanese companies, particularly at the preclinical and early clinical stages
The product is approved as bioequivalent to Xigduo XR for the indications outlined in the reference drug’s labelling
Inspection outcome reinforces company's compliance track record and strengthens its ability to serve regulated markets including the United States
The company announced that its Phase III FENhance 1 and 2 studies both met their primary endpoints
The collaboration underscores a broader industry shift toward hybrid research models that integrate computational biology with advanced experimental systems
Bulling brings extensive experience across the biopharma and CDMO landscape, with leadership roles spanning both drug substance and drug product operations
New regional hub strengthens presence in a key market and enhances service delivery for corporate healthcare clients
Pharma giant targets new standards of care
Subscribe To Our Newsletter & Stay Updated
